Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 62,043 | 153,731 | 67,772 | 61,880 | 42,722 |
| Gross Profit | 62,043 | 153,731 | 67,772 | 61,880 | 42,722 |
| Operating Expenses | 300,496 | 243,009 | 196,715 | 160,404 | 113,779 |
| Operating Income | -238,453 | -89,278 | -128,943 | -98,524 | -71,057 |
| Interest Expense | 0 | 0 | 0 | 3,137 | 3,974 |
| Other Income | 13,355 | 677 | 12,239 | -3,877 | 43,006 |
| Pre-tax Income | -225,098 | -88,601 | -116,704 | -105,538 | -32,025 |
| Income Tax | 2,363 | 18,192 | 2,500 | N/A | 103 |
| Net Income Continuous | -227,461 | -106,793 | -119,204 | -105,538 | -32,128 |
| Net Income | $-227,461 | $-106,793 | $-119,204 | $-105,538 | $-32,128 |
| EPS Basic Total Ops | -29.60 | -17.80 | -23.50 | -22.90 | -9.90 |
| EPS Basic Continuous Ops | -29.61 | -17.75 | -23.49 | -22.88 | -9.86 |
| EPS Diluted Total Ops | -29.60 | -17.80 | -23.50 | -22.90 | -9.90 |
| EPS Diluted Continuous Ops | -29.61 | -17.75 | -23.49 | -22.88 | -9.86 |
| EPS Diluted Before Non-Recurring Items | -29.60 | -19.10 | -23.50 | -20.60 | -20.00 |
| EBITDA(a) | $-240,954 | $-91,537 | $-123,617 | $-90,899 | $-66,270 |